PeptideDB

K90-114TAT

CAS: F: C205H357N77O55 W: 4780.51

K90-114TAT is an inhibitor for EAG2-Kvβ2 interaction, and exhibits antitumor efficacy against glioblastomas.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity K90-114TAT is an inhibitor for EAG2-Kvβ2 interaction, and exhibits antitumor efficacy against glioblastomas[1].
Sequence Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Gln-Gly-Ser-Gly-Ser-Gly-Ser-Tyr-Ala-Ala-Gly-Lys-Ala-Glu-Val-Val-Leu-Gly-Asn-Ile-Ile-Lys-Lys-Lys-Gly-Trp-Arg-Arg-Ser-Ser-Leu-Val
Shortening GRKKRRQRRRPQGSGSGSYAAGKAEVVLGNIIKKKGWRRSSLV
Formula C205H357N77O55
Molar Mass 4780.51
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Yang Y, et al., CNSC-30. IN VIVO DYNAMICS OF ASTROCYTE-GLIOBLASTOMA TUMOR NETWORKS[J]. Neuro-Oncology, 2022, 24